1
|
Pateneaude C, Lyden C. Diagnosis and management of diverticular disease in primary care. Nurse Pract 2024; 49:23-29. [PMID: 39467838 DOI: 10.1097/01.npr.0000000000000243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/30/2024]
Abstract
ABSTRACT Each year, more than 1 million ambulatory patient visits occur for diverticular disease, with nearly 75% of these patients seen in outpatient clinics. Although diverticulitis historically had been considered a disease of the older adult, it has become increasingly prevalent among the younger population. Likewise, in the past, antibiotics were considered first-line treatment for uncomplicated diverticulitis (Hinchey classification 0 and Ia); however, two large clinical trials compared treatment with antibiotics versus without antibiotics in uncomplicated cases of the disease and found no significant difference in patient outcomes. Based on these findings, first-line management now constitutes clear-liquid diet along with bowel rest for resolution of symptoms in these patients. Proper management with lifestyle modifications can help prevent complications and improve outcomes for patients with this condition; patient education is therefore critical.
Collapse
|
2
|
Mcleod M, Campbell A, Hayhoe B, Borek AJ, Tonkin-Crine S, Moore MV, Butler CC, Walker AS, Holmes A, Wong G. How, why and when are delayed (back-up) antibiotic prescriptions used in primary care? A realist review integrating concepts of uncertainty in healthcare. BMC Public Health 2024; 24:2820. [PMID: 39402467 PMCID: PMC11476980 DOI: 10.1186/s12889-024-20248-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2024] [Accepted: 10/01/2024] [Indexed: 10/19/2024] Open
Abstract
BACKGROUND Antimicrobial resistance is a global patient safety priority and inappropriate antimicrobial use is a key contributing factor. Evidence have shown that delayed (back-up) antibiotic prescriptions (DP) are an effective and safe strategy for reducing unnecessary antibiotic consumption but its use is controversial. METHODS We conducted a realist review to ask why, how, and in what contexts general practitioners (GPs) use DP. We searched five electronic databases for relevant articles and included DP-related data from interviews with healthcare professionals in a related study. Data were analysed using a realist theory-driven approach - theorising which context(s) influenced (mechanisms) resultant outcome(s) (context-mechanism-outcome-configurations: CMOCs). RESULTS Data were included from 76 articles and 41 interviews to develop a program theory comprising nine key and 56 related CMOCs. These explain the reasons for GPs' tolerance of risk to different uncertainties and how these may interact with GPs' work environment, self-efficacy and perceived patient concordance to make using DP as a safety-net or social tool more or less likely, at a given time-point. For example, when a GP uses clinical scores or diagnostic tests: a clearly high or low score/test result may mitigate scientific uncertainty and lead to an immediate or no antibiotic decision; an intermediary result may provoke hermeneutic (interpretation-related) uncertainty and lead to DP becoming preferred and used as a safety net. Our program theory explains how DP can be used to mitigate some uncertainties but also provoke or exacerbate others. CONCLUSION This review explains how, why and in what contexts GPs are more or less likely to use DP, as well as various uncertainties GPs face which DP may mitigate or provoke. We recommend that efforts to plan and implement interventions to optimise antibiotic prescribing in primary care consider these uncertainties and the contexts when DP may be (dis)preferred over other interventions to reduce antibiotic prescribing. We also recommend the following and have included example activities for: (i) reducing demand for immediate antibiotics; (ii) framing DP as an 'active' prescribing option; (iii) documenting the decision-making process around DP; and (iv) facilitating social and system support.
Collapse
Grants
- ES/P008232/1 Economic and Social Research Council, UK
- ES/P008232/1 Economic and Social Research Council, UK
- ES/P008232/1 Economic and Social Research Council, UK
- ES/P008232/1 Economic and Social Research Council, UK
- ES/P008232/1 Economic and Social Research Council, UK
- ES/P008232/1 Economic and Social Research Council, UK
- ES/P008232/1 Economic and Social Research Council, UK
- ES/P008232/1 Economic and Social Research Council, UK
- ES/P008232/1 Economic and Social Research Council, UK
- ES/P008232/1 Economic and Social Research Council, UK
Collapse
Affiliation(s)
- Monsey Mcleod
- National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK
- NIHR Imperial Patient Safety Translational Research Centre, Imperial College London, London, UK
| | - Anne Campbell
- National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK
| | - Benedict Hayhoe
- Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK
- NIHR Applied Research Collaboration Northwest London, London, UK
| | - Aleksandra J Borek
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
| | - Sarah Tonkin-Crine
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
- NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK
| | - Michael V Moore
- Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK
| | - Christopher C Butler
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
| | - A Sarah Walker
- NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK
- NIHR Oxford Biomedical Research Centre, Oxford, UK
- Nuffield Department of Medicine, University of Oxford, Oxford, UK
| | - Alison Holmes
- National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK
| | - Geoff Wong
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
| |
Collapse
|
3
|
Smith SS, Caliendo A, Cheng BT, Kern RC, Holl J, Linder JA, Cameron KA. Patient Perspectives on the Drivers and Deterrents of Antibiotic Treatment of Acute Rhinosinusitis: a Qualitative Study. J Gen Intern Med 2023; 38:683-690. [PMID: 36258155 PMCID: PMC9971408 DOI: 10.1007/s11606-022-07811-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2022] [Accepted: 09/13/2022] [Indexed: 10/24/2022]
Abstract
BACKGROUND Antibiotics are prescribed in >80% of outpatient acute rhinosinusitis (ARS) visits, despite the low incidence of bacterial infection. Previous studies have shown patient expectations are the most robust predictor of antibiotics prescription in ARS. However, patient perceptions are not well known or understood. OBJECTIVE To understand patient perceptions regarding what drives or deters them from wanting, seeking, and taking antibiotic treatment of ARS. DESIGN Iterative thematic analysis of semi-structured interviews. PARTICIPANTS Nineteen adults diagnosed with ARS within the prior 60 days at the Northwestern Medicine General Internal Medicine clinic in Chicago, IL. MAIN MEASURES Perceptions of patients with ARS. KEY RESULTS We interviewed 19 patients, identifying the following drivers of antibiotic use: (1) symptoms, especially discolored rhinorrhea, and seeking relief, (2) belief that antibiotics are a convenient and/or effective way to relieve/cure sinusitis, and (3) desire for tangible outcomes of a clinic visit. For deterrents, the following themes emerged: (1) concern about antibiotic resistance, (2) preference for other treatments or preference to avoid medications, and (3) desire to avoid a healthcare visit. Patients identified that a trustworthy physician's recommendation for antibiotics was a driver, and a recommendation against antibiotics was a deterrent to taking antibiotics; a delayed antibiotic prescription also served as a deterrent. Antibiotic side effects were viewed neutrally by most participants, though they were a deterrent to some. CONCLUSIONS Patients have misconceptions about the indications and effectiveness of antibiotics for ARS. Intimate knowledge of key antibiotic drivers and deterrents, from the perspective of patients with ARS, can be leveraged to engage and increase patients' knowledge, and set appropriate expectations for antibiotics for ARS.
Collapse
Affiliation(s)
- Stephanie Shintani Smith
- Department of Otolaryngology - Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
- Center for Health Services and Outcomes Research, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
| | - Anne Caliendo
- Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Brian T Cheng
- Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Robert C Kern
- Department of Otolaryngology - Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Jane Holl
- Department of Neurology, Biological Sciences Division, University of Chicago, Chicago, IL, USA
- Center for Healthcare Delivery Science and Innovation, University of Chicago, Chicago, IL, USA
| | - Jeffrey A Linder
- Center for Primary Care Innovation, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- Division of General Internal Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Kenzie A Cameron
- Center for Health Services and Outcomes Research, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- Center for Primary Care Innovation, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- Division of General Internal Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| |
Collapse
|
4
|
Does poverty increase antibiotic prescribing rates through underlying health conditions? Ecological study using parallel mediation analysis. ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY : ASHE 2023; 3:e21. [PMID: 36819769 PMCID: PMC9932640 DOI: 10.1017/ash.2022.372] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/04/2022] [Revised: 12/02/2022] [Accepted: 12/08/2022] [Indexed: 01/31/2023]
Abstract
Objective Effect of social determinants on antibiotic prescribing rates is poorly studied in modern literature. The objective of this study was to explore the effect of the prevalence of poverty (annual household income <$24,999) in each state on antibiotic prescribing rates in outpatient settings per 1,000 population through chronic health conditions (ie, prevalence of obesity, diabetes, and chronic obstructive pulmonary disease) while also adjusting for confounders (ie, prevalence of population aged ≥65 years and physician density in each state). Design Ecological study. Participants Entire US population. Methods Prevalence estimates from all 51 states were used to calculate direct, indirect, and total effects of poverty on the rates of antibiotic prescribing through parallel mediation analysis using linear regression with chronic health conditions (obesity, diabetes, and chronic obstructive pulmonary disease) as mediators. I obtained these data from point-prevalence estimates of 2020 survey results from the Behavioral Risk Factor Surveillance System for rates on poverty, obesity, diabetes, chronic obstructive pulmonary disease, and population aged ≥ 65 years. I also used the Antibiotic Resistance & Patient Safety Portal for antibiotic prescribing rates per 1,000 population and the Association of American Medical Colleges database for the physician density per 100,000 population. Results For every percentage increase in prevalence of poverty in each state, the antibiotic prescribing rate increased by 17.4 courses per 1,000 population (95% bootstrap confidence interval, 9.2-24.9) using indirect effects of poverty through mediators. Conclusions Antibiotic stewardship programs should consider targeting social determinants of health along with underlying health conditions of patients being treated with antibiotics.
Collapse
|
5
|
Barbazza E, Verheij RA, Ramerman L, Klazinga N, Kringos D. Optimising the secondary use of primary care prescribing data to improve quality of care: a qualitative analysis. BMJ Open 2022; 12:e062349. [PMID: 35863830 PMCID: PMC9310167 DOI: 10.1136/bmjopen-2022-062349] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
OBJECTIVES To explore available data sources, secondary uses and key considerations for optimising the actionability of primary care prescribing data to improve quality of care in the Dutch context. DESIGN An exploratory qualitative study was undertaken based on semi-structured interviews. We anchored our investigation around three tracer prescription types: antibiotics; benzodiazepines and opioids. Descriptive and explanatory themes were derived from interview data using thematic analysis. SETTING Stakeholders were sampled from across the micro (clinical), meso (organisational) and macro (policy) contexts of the Dutch primary care system. PARTICIPANTS The study involved 28 informants representing general practitioners (GPs), community pharmacists, regional chronic care networks (care groups), academia and research institutes, insurers, professional associations, electronic health record (EHR) vendors and national authorities. RESULTS In the Netherlands, three main sources of data for improving prescribing in primary care are in use: clinical data in the EHRs of GP practices; pharmacy data in community pharmacy databases and claims data of insurers. While the secondary use of pharmacy and claims data is well-established across levels, the use of these data together with EHR data is limited. Important differences in the types of prescribing information needed by micro-meso-macro context are found, though the extent to which current indicators address these varies by prescription type. Five main themes were identified as areas for optimising data use: (1) measuring what matters, (2) increasing data linkages, (3) improving data quality, (4) facilitating data sharing and (5) optimising fit for use analysis. CONCLUSIONS To make primary care prescribing data useful for improving quality, consolidated patient-specific data on the indication for a prescription and dispensed medicine, over time, is needed. In the Netherlands, the selection of indicators requires further prioritisation to better signal the appropriateness and long-term use of prescription drugs. Prioritising data linkages is critical towards more actionable use.
Collapse
Affiliation(s)
- Erica Barbazza
- Department of Public and Occupational Health, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands
| | - Robert A Verheij
- Learning Health Systems Research Programme, Netherlands Institute for Health Services Research, Utrecht, The Netherlands
| | - Lotte Ramerman
- Learning Health Systems Research Programme, Netherlands Institute for Health Services Research, Utrecht, The Netherlands
| | - Niek Klazinga
- Department of Public and Occupational Health, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands
| | - Dionne Kringos
- Department of Public and Occupational Health, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands
| |
Collapse
|
6
|
Antibiotic stewardship to reduce inappropriate antibiotic prescribing in integrated academic health-system urgent care clinics. Infect Control Hosp Epidemiol 2022; 44:736-745. [DOI: 10.1017/ice.2022.164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Abstract
Objective:
To develop and implement antibiotic stewardship activities in urgent care targeting non–antibiotic-appropriate acute respiratory tract infections (ARIs) that also reduces overall antibiotic prescribing and maintains patient satisfaction.
Patients and setting:
Patients and clinicians at the urgent care clinics of an integrated academic health system.
Intervention and methods:
The stewardship activities started in fiscal 2020 and included measure development, comparative feedback, and clinician and patient education. We measured antibiotic prescribing in fiscal years 2019, 2020, and 2021 for the stewardship targets, potential diagnosis-shifting visits, and overall. We also collected patient satisfaction data for ARI visits.
Results:
From FY19 to FY21, 576,609 patients made 1,358,816 visits to 17 urgent care clinics, including 105,781 visits for which stewardship measures were applied and 149,691 visits for which diagnosis shifting measures were applied. The antibiotic prescribing rate decreased for stewardship-measure visits from 34% in FY19 to 12% in FY21 (absolute change, −22%; 95% confidence interval [CI], −23% to −22%). The antibiotic prescribing rate decreased for diagnosis-shifting visits from 63% to 35% (−28%; 95% CI, −28% to −27%), and the antibiotic prescribing rate decreased overall from 30% to 10% (−20%; 95% CI, −20% to −20%). The patient satisfaction rate increased from 83% in FY19 to 89% in FY20 and FY21. There was no significant association between antibiotic prescribing rates of individual clinicians and ARI visit patient satisfaction.
Conclusions:
Although it was affected by the COVID-19 pandemic, an ambulatory antimicrobial stewardship program that focused on improving non–antibiotic-appropriate ARI prescribing was associated with decreased prescribing for (1) the stewardship target, (2) a diagnosis shifting measure, and (3) overall antibiotic prescribing. Patient satisfaction at ARI visits increased over time and was not associated with clinicians’ antibiotic prescribing rates.
Collapse
|
7
|
Essigmann HT, Aguilar DA, Perkison WB, Bay KG, Deaton MR, Brown SA, Hanis CL, Brown EL. Epidemiology of Antibiotic Use and Drivers of Cross-Border Procurement in a Mexican American Border Community. Front Public Health 2022; 10:832266. [PMID: 35356027 PMCID: PMC8960039 DOI: 10.3389/fpubh.2022.832266] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2021] [Accepted: 02/10/2022] [Indexed: 11/13/2022] Open
Abstract
Background The U.S.-Mexico Border is an area of opportunity for improved health care access; however, gaps remain as to how and where U.S. border residents, particularly those who are underinsured, obtain care. Antibiotics are one of the most common reported drivers of cross-border healthcare access and a medication of particular concern since indiscriminate or inappropriate use is associated with antimicrobial resistance. In addition, many studies assessing preferences for Mexican pharmaceuticals and healthcare in U.S. border residents were done prior to 2010 when many prescription medications, including antibiotics, were available over the counter in Mexico. Methods Data used in this study were collected during the baseline examination of an ongoing longitudinal cohort study in Starr Country, Texas, one of 14 counties on the Texas-Mexico border. Participants self-reported the name, date of use, and the source country of each antibiotic used in the past 12 months. Logistic regression was used to determine social, cultural, and clinical features associated with cross-border procurement of antibiotics. Results Over 10% of the study cohort reported using antibiotics in the past 30 days with over 60% of all rounds used in the past 12 months sourced from Mexico. A lack of health insurance and generation score, a measure of acculturation, were the strongest predictors of cross-border procurement of antibiotics. Conclusions Factors previously associated with cross-border acquisition of antibiotics are still present despite changes in 2010 to prescription drug regulations in Mexico. These results may be used to inform future public health initiatives to provide culturally sensitive education about responsible antibiotic stewardship and to address barriers to U.S. healthcare and pharmaceutical access in medically underserved, impoverished U.S.-Mexico border communities.
Collapse
Affiliation(s)
- Heather T. Essigmann
- Division of Epidemiology, Human Genetics, and Environmental Sciences, Center for Infectious Disease, University of Texas Health Science Center, Houston, TX, United States
| | - David A. Aguilar
- Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, United States
| | - William B. Perkison
- Division of Epidemiology, Human Genetics, and Environmental Sciences, Human Genetics Center, University of Texas Health Science Center at Houston, Houston, TX, United States
| | - Katherine G. Bay
- Division of Epidemiology, Human Genetics, and Environmental Sciences, Human Genetics Center, University of Texas Health Science Center at Houston, Houston, TX, United States
| | - Magdalena R. Deaton
- Division of Epidemiology, Human Genetics, and Environmental Sciences, Human Genetics Center, University of Texas Health Science Center at Houston, Houston, TX, United States
| | - Sharon A. Brown
- School of Nursing, University of Texas at Austin, Austin, TX, United States
| | - Craig L. Hanis
- Division of Epidemiology, Human Genetics, and Environmental Sciences, Human Genetics Center, University of Texas Health Science Center at Houston, Houston, TX, United States
| | - Eric L. Brown
- Division of Epidemiology, Human Genetics, and Environmental Sciences, Center for Infectious Disease, University of Texas Health Science Center, Houston, TX, United States
| |
Collapse
|
8
|
Xu J, Huang J, Yu Y, Zhou D, Wang Y, Xue S, Shang E, Sun J, Ding X, Shi L, Duan L, Tang L, Zhou Q, Li X. The Impact of a Multifaceted Pharmacist-Led Antimicrobial Stewardship Program on Antibiotic Use: Evidence From a Quasi-Experimental Study in the Department of Vascular and Interventional Radiology in a Chinese Tertiary Hospital. Front Pharmacol 2022; 13:832078. [PMID: 35295325 PMCID: PMC8919369 DOI: 10.3389/fphar.2022.832078] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2021] [Accepted: 01/13/2022] [Indexed: 11/13/2022] Open
Abstract
Objective: The objective of the study was to assess the impact of multifaceted clinical pharmacist-led antimicrobial stewardship (AMS) program on the rational use of antibiotics for patients who receive vascular and interventional radiology therapies. Methods: A quasi-experimental retrospective intervention design with a comparison group was applied to the practice of antibiotic use in the department of vascular and interventional radiology in a Chinese tertiary hospital. We used difference-in-differences (DID) analysis to compare outcomes before and after the AMS intervention between the intervention group and control group, to determine whether intervention would lead to changes in irrationality of antibiotic prescribing, antibiotic utilization, cost of antibiotics, and length of hospital stay. Results: The DID results showed that the intervention group was associated with a reduction in the average consumption of antibiotics (p = 0.017) and cost of antibiotics (p = 0.006) and cost per defined daily dose (DDD) (p = 0.000). There were no significant differences in the mean change of total costs and length of stay between the two groups (p > 0.05). The average inappropriate score of perioperative antimicrobial prophylaxis in the intervention group declined by 0.23, while it decreased by 0.02 in the control group [0.21 (95% CI, -0.271 to -0.143); p = 0.000]. The average inappropriate score of non-surgical antimicrobial prophylaxis in the intervention group declined by 0.14, while it increased by 0.02 in the control group [0.16 (95% CI, -0.288 to -0.035); p = 0.010]. The average inappropriate score of the therapeutic use of antibiotics in the intervention group declined by 0.07, while it decreased by 0.01 in the control group [0.06 (95% CI, -0.115 to -0.022); p = 0.003]. Conclusions: This study provides evidence that implementation of AMS interventions was associated with a marked reduction of antibiotic use, cost of antibiotics, and irrationality of antibiotic prescribing in China.
Collapse
Affiliation(s)
- Jinhui Xu
- Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - Jian Huang
- Department of Vascular and Interventional Radiology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - YanXia Yu
- Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - Dayong Zhou
- Department of Vascular and Interventional Radiology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - Ying Wang
- Department of Education and Training, The First Affiliated Hospital of SooChow University, SuZhou, China
| | - Sudong Xue
- Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - Erning Shang
- Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - Jiantong Sun
- Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - Xinyuan Ding
- Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - Lu Shi
- Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - Lufen Duan
- Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - Lian Tang
- Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - Qin Zhou
- Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - Xin Li
- Department of Clinical Pharmacy, School of Pharmacy, Nanjing Medical University, Nanjing, China
- Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China
| |
Collapse
|
9
|
Walters JH, Stevens MP, Kim J. Evaluation of optimal treatment for urinary tract infections in outpatient clinics at an academic medical center: Opportunities for antimicrobial stewardship. Am J Infect Control 2022; 50:114-115. [PMID: 34273462 DOI: 10.1016/j.ajic.2021.07.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2021] [Revised: 07/08/2021] [Accepted: 07/09/2021] [Indexed: 11/01/2022]
Abstract
Outpatient empiric urinary tract infection (UTI) prescribing is an area of interest for antimicrobial stewardship efforts. We conducted a retrospective chart review evaluating optimal antibiotic prescribing for UTIs in our internal medicine and urology clinics and found significant differences in prescribing patterns between provider type and UTI category. These data will inform our antimicrobial stewardship efforts in these clinics.
Collapse
|
10
|
Hashmi H, Sasoli NA, Sadiq A, Raziq A, Batool F, Raza S, Iqbal Q, Haider S, Umer Jan S, Mengal MA, Tareen AM, Khalid A, Saleem F. Prescribing Patterns for Upper Respiratory Tract Infections: A Prescription-Review of Primary Care Practice in Quetta, Pakistan and the Implications. Front Public Health 2021; 9:787933. [PMID: 34869195 PMCID: PMC8640527 DOI: 10.3389/fpubh.2021.787933] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2021] [Accepted: 10/27/2021] [Indexed: 11/17/2022] Open
Abstract
Background: To identify and address the potential overuse of antibiotics, it is important to ascertain the prescribing practices of physicians. We, therefore, conducted this prescription analysis to document URTI-specific antibiotic prescription frequency in a public primary healthcare setting of Quetta city, Pakistan. Methods: A retrospective record review was conducted of all prescriptions for URTIs in Combined Military Hospital, Quetta from 1 March to 31st May 2021. The Mann-Whitney U and Jonckheere–Terpstra test was used to evaluate the association between the tendencies of a different group of prescribers. p-value of <0.05 was of statistical significance. Results: Over the 3 months, 50,705 prescriptions were screened and analyzed according to the established inclusion and exclusion criteria. A total of 4,126 (8.13%) URTI prescriptions met the inclusion criteria, of which 2,880 (69.80%) prescriptions contained antibiotics. Among all antibiotics, penicillins (Amoxicillin + Clavulanate) were the most prescribed antibiotic, constituting 1,323 (45.9%) of total antibiotics prescribed for all cases, followed by the Macrolide group 527 (18.2%). The Jonckheere–Terpstra test revealed a statistically significant association between the status of the prescriber and the diagnosis (p = 0.002). Furthermore, a moderate positive trend was reported with specialists being more competent in antibiotic prescribing based on their diagnosis, followed by postgraduates and house officers (τ = 0.322). Conclusion: The prescribing patterns for the management of URTIs in the hospital were inconsistent with current guidelines. Strict adherence to guidelines must be ensured and antibiotic prescribing for URTIs should be discouraged.
Collapse
Affiliation(s)
- Hania Hashmi
- Faculty of Pharmacy and Health Sciences, University of Baluchistan, Quetta, Pakistan
| | | | - Abdul Sadiq
- Department of Biochemistry, Jhalawan Medical College Khuzdar, Khuzdar, Pakistan
| | - Abdul Raziq
- Department of Statistics, University of Baluchistan, Quetta, Pakistan
| | - Fakhra Batool
- Department of Pharmacy, Sardar Bahadur Khan Women's University, Quetta, Pakistan
| | - Shanaz Raza
- Department of Pharmacy, Sardar Bahadur Khan Women's University, Quetta, Pakistan
| | - Qaiser Iqbal
- Faculty of Pharmacy and Health Sciences, University of Baluchistan, Quetta, Pakistan
| | - Sajjad Haider
- Faculty of Pharmacy and Health Sciences, University of Baluchistan, Quetta, Pakistan
| | - Syed Umer Jan
- Faculty of Pharmacy and Health Sciences, University of Baluchistan, Quetta, Pakistan
| | - Muhammad Alam Mengal
- Center for Advanced Studies in Vaccinology and Biotechnology, University of Baluchistan, Quetta, Pakistan
| | | | - Adnan Khalid
- Department of Surgery, Combined Military Hospital, Quetta, Pakistan
| | - Fahad Saleem
- Faculty of Pharmacy and Health Sciences, University of Baluchistan, Quetta, Pakistan
| |
Collapse
|
11
|
De Seta F, Larsen B. Antimicrobial Activity of a Vaginal Gel Formulation: Considerations Related to Vaginal Infection and Dysbiosis. Pathogens 2021; 10:pathogens10121576. [PMID: 34959532 PMCID: PMC8706553 DOI: 10.3390/pathogens10121576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2021] [Revised: 11/29/2021] [Accepted: 11/30/2021] [Indexed: 11/16/2022] Open
Abstract
Many non-prescription preparations intended to treat or alleviate symptoms of vaginal infection are available in American and European markets, but many have scant preclinical or clinical research underpinning. Respecta®Balance Gel (RBG) is marketed as an adjunct to probiotic treatment and its relevant antimicrobial properties were studied. Key findings with the manufacturer-supplied gel showed reduced turbidity in broth-dilution tests by 50% against Candida albicans and Candida glabrata at RBG concentrations 0.2-0.4% of neat product, respectively. A 50% reduction in turbidity of Escherichia coli, Streptococcus agalactiae, Enterococcus faecalis ranged from 1.6-2.2% and Gardnerella vaginalis was shown by flow cytometry counts to undergo a 50% reduction at 0.3% RBG. Propidium iodide staining indicated a rapid reduction of cell integrity of G. vaginalis almost immediately while after 4 h 45% of E. coli cells were stained. The lactic acid in BHI inhibited bacteria and yeast at concentrations ranging from 0.2-1.8% but inhibition was not solely due to pH since a 1:4 dilution of RBG resulted in a pH near neutral (6.75). Other findings showed biofilm accumulation assessed after 10-days exposure of Candida spp. to RBG and was reduced by an average of one-third (community strains) to one-half (drug-resistant strains). One excipient of the RBG, disodium EDTA, inhibited the growth of bacteria and yeast at concentrations below those present in RBG and may accentuate the activity of the host defense factor, lactoferrin. We conclude that RBG is a potent inhibitor of vaginal microorganisms relevant to vaginitis or intrapartum infections and contains excipients that may contribute to its antimicrobial activity.
Collapse
Affiliation(s)
- Francesco De Seta
- Department of Medical Sciences, University of Trieste, 34149 Trieste, Italy;
- Institute for Maternal and Child Health IRCCS “Burlo Garofolo”, 34137 Trieste, Italy
| | - Bryan Larsen
- College of Osteopathic Medicine, Marian University, 3200 Cold Spring Road, Indianapolis, IN 46222, USA
- Correspondence:
| |
Collapse
|
12
|
Li LX, Szymczak JE, Keller SC. Antibiotic stewardship in direct-to-consumer telemedicine: translating interventions into the virtual realm. J Antimicrob Chemother 2021; 77:13-15. [PMID: 34618026 DOI: 10.1093/jac/dkab371] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023] Open
Abstract
Direct-to-consumer (DTC) telemedicine is an increasingly popular modality for delivery of medical care via a virtual platform. As most DTC telemedicine visits focus on infection-related complaints, there is growing concern about the magnitude of antibiotic use associated with this setting. However, there is limited scholarship regarding adapting and implementing antibiotic stewardship principles in this setting as most efforts have been focused on hospitals with more recent work in long-term care facilities and primary care settings. We discuss utilizing the core elements for outpatient antibiotic stewardship as a framework for DTC antibiotic stewardship efforts moving forward.
Collapse
Affiliation(s)
- Lucy X Li
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Julia E Szymczak
- Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
| | - Sara C Keller
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| |
Collapse
|
13
|
Shi Z, Barnett ML, Jena AB, Ray KN, Fox KP, Mehrotra A. Association of a Clinician's Antibiotic-Prescribing Rate With Patients' Future Likelihood of Seeking Care and Receipt of Antibiotics. Clin Infect Dis 2021; 73:e1672-e1679. [PMID: 32777032 PMCID: PMC8492129 DOI: 10.1093/cid/ciaa1173] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Indexed: 11/29/2022] Open
Abstract
Background One underexplored driver of inappropriate antibiotic prescribing for acute respiratory illnesses (ARI) is patients’ prior care experiences. When patients receive antibiotics for an ARI, patients may attribute their clinical improvement to the antibiotics, regardless of their true benefit. These experiences, and experiences of family members, may drive whether patients seek care or request antibiotics for subsequent ARIs. Methods Using encounter data from a national United States insurer, we identified patients <65 years old with an index ARI urgent care center (UCC) visit. We categorized clinicians within each UCC into quartiles based on their ARI antibiotic prescribing rate. Exploiting the quasi-random assignment of patients to a clinician within an UCC, we examined the association between the clinician’s antibiotic prescribing rate to the patients’ and their spouses’ rates of ARI antibiotic receipt in the subsequent year. Results Across 232,256 visits at 736 UCCs, ARI antibiotic prescribing rates were 42.1% and 80.2% in the lowest and highest quartile of clinicians, respectively. Patient characteristics were similar across the four quartiles. In the year after the index ARI visit, patients seen by the highest-prescribing clinicians received more ARI antibiotics (+3.0 fills/100 patients (a 14.6% difference), 95% CI 2.2–3.8, P < 0.001,) versus those seen by the lowest-prescribing clinicians. The increase in antibiotics was also observed among the patients’ spouses. The increase in patient ARI antibiotic prescriptions was largely driven by an increased number of ARI visits (+5.6 ARI visits/100 patients, 95% CI 3.6–7.7, P < 0.001), rather than a higher antibiotic prescribing rate during those subsequent ARI visits. Conclusions Receipt of antibiotics for an ARI increases the likelihood that patients and their spouses will receive antibiotics for future ARIs.
Collapse
Affiliation(s)
- Zhuo Shi
- Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
| | - Michael L Barnett
- Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.,Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA
| | - Anupam B Jena
- Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.,Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.,National Bureau of Economic Research, Cambridge, Massachusetts, USA
| | - Kristin N Ray
- Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
| | - Kathe P Fox
- Department of Analytics and Behavior Change, Aetna/CVS Health, Baltimore, Maryland, USA
| | - Ateev Mehrotra
- Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.,Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
| |
Collapse
|
14
|
Fleming N, Wilson J, Crawford S, Feeney S. A Quality Improvement Initiative to Improve Antibiotic Stewardship at a Federally Qualified Health Center. J Nurse Pract 2021. [DOI: 10.1016/j.nurpra.2021.04.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
15
|
Knobloch MJ, Musuuza J, Baubie K, Saban KL, Suda KJ, Safdar N. Nurse practitioners as antibiotic stewards: Examining prescribing patterns and perceptions. Am J Infect Control 2021; 49:1052-1057. [PMID: 33524451 DOI: 10.1016/j.ajic.2021.01.018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2020] [Revised: 01/19/2021] [Accepted: 01/20/2021] [Indexed: 01/21/2023]
Abstract
BACKGROUND Advanced practice providers in the outpatient setting play a key role in antibiotic stewardship, yet little is known about how to engage these providers in stewardship activities and what factors influence their antibiotic prescribing practices. METHODS We used mixed methods to obtain data on practices and perceptions related to antibiotic prescribing by nurse practitioners (NP) and Veteran patients. We interviewed NPs working in the outpatient setting at one Veterans Affairs facility and conducted focus groups with Veterans. Emerging themes were mapped to the Systems Engineering Initiative for Patient Safety framework. We examined NP antibiotic prescribing data from 2017 to 2019. RESULTS We interviewed NPs and conducted Veteran focus groups. Nurse practitioners reported satisfaction with resources, including ready access to pharmacists and infectious disease specialists. Building patient trust was reported as essential to prescribing confidence level. Veterans indicated the need to better understand differences between viral and bacterial infections. NP prescribing patterns revealed a decline in antibiotics prescribed for upper respiratory illnesses over a 3-year period. CONCLUSION Outpatient NPs focus on educating the patient while balancing organizational access challenges. Further research is needed to determine how to include both NPs and patients when implementing outpatient antibiotic stewardship strategies. Further research is also needed to understand factors associated with the decline in nurse practitioner antibiotic prescribing observed in this study.
Collapse
|
16
|
Ozturk GZ, Toprak D, Sagsoz O, Ardic C. Knowledge, Attitude and Practice of Family Physicians on Antimicrobial Therapy for Acute Respiratory Tract Infections - A Study from Istanbul, Turkey. EURASIAN JOURNAL OF FAMILY MEDICINE 2021. [DOI: 10.33880/ejfm.2021100202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Aim: We aimed to investigate the knowledge, attitude, practice of family physicians regarding an-timicrobial therapy in acute respiratory tract infections.
Methods: After receiving the ethics committee approval, the data were collected by online questionnaire from a phone application with 304 physicians. Questions about socio-demographic features and knowledge, attitude, and practices on antibiotics use were asked. Using SPSS, we did the statistical analyses with appropriate procedures.
Results: Among the participants, 127 (41.8%) were specialists, and 177 (58.2%) were gen-eral practitioners. The specialists gave correct answers about tonsillopharyngitis and bron-chiolitis significantly more often than the general practitioners did. The antibiotic choices for acute otitis media were not in compliance with the guidelines of the Centers for Disease Control, and between the groups, there was no significant difference in terms of initial antibiotic choice. The self-reported antibiotic prescription rate was 25%. In 10%, the most common perceived reason for inappropriate antibiotic prescription was pressure from patients.
Conclusion: There remains considerable misuse of antibiotics by primary care physicians for acute respiratory tract infections. Education of physicians and patients regarding acute respiratory tract infections may be needed to lower the rate of inappropriate antibiotic pre-scriptions.
Keywords: public health practice, practice patterns, primary healthcare
Collapse
Affiliation(s)
| | | | | | - Cuneyt Ardic
- Recep Tayyip Erdoğan University Faculty of Medicine
| |
Collapse
|
17
|
Mullakary J, Visintainer S, Tucci M, Dionne B, Conley MP, Reid DJ, Matta TM, Bartucca MA, Bouwmeester CJ. A multicenter retrospective review of antibiotic prescribing patterns for treatment of urinary tract infections in the primary care setting. JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2021. [DOI: 10.1002/jac5.1430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Jenny Mullakary
- Department of Pharmacy and Health Systems Sciences Northeastern University Boston Massachusetts USA
- Harbor Health Services, Inc. Mattapan Massachusetts USA
- Clinical Pharmacy Department Atrius Health Watertown Massachusetts USA
| | - Sarah Visintainer
- Department of Pharmacy and Health Systems Sciences Northeastern University Boston Massachusetts USA
- Harbor Health Elder Service Plan Mattapan Massachusetts USA
- Clinical Pharmacy Department Shields Health Solutions Stoughton Massachusetts USA
| | - Mitchell Tucci
- Department of Pharmacy and Health Systems Sciences Northeastern University Boston Massachusetts USA
- The Dimock Center Roxbury Massachusetts USA
- Pharmacy Department CVS Pharmacy Boston Massachusetts USA
| | - Brandon Dionne
- Department of Pharmacy and Health Systems Sciences Northeastern University Boston Massachusetts USA
- Brigham and Women's Hospital Boston Massachusetts USA
| | - Michael P. Conley
- Department of Pharmacy and Health Systems Sciences Northeastern University Boston Massachusetts USA
- Harbor Health Services, Inc. Mattapan Massachusetts USA
| | - Debra J. Reid
- Department of Pharmacy and Health Systems Sciences Northeastern University Boston Massachusetts USA
- The Dimock Center Roxbury Massachusetts USA
| | - Thomas M. Matta
- Department of Pharmacy and Health Systems Sciences Northeastern University Boston Massachusetts USA
- Harbor Health Services, Inc. Mattapan Massachusetts USA
| | - Macayla A. Bartucca
- Department of Pharmacy and Health Systems Sciences Northeastern University Boston Massachusetts USA
- Harbor Health Elder Service Plan Mattapan Massachusetts USA
| | - Carla J. Bouwmeester
- Department of Pharmacy and Health Systems Sciences Northeastern University Boston Massachusetts USA
- Harbor Health Elder Service Plan Mattapan Massachusetts USA
| |
Collapse
|
18
|
Truitt KN, Brown T, Lee JY, Linder JA. Appropriateness of Antibiotic Prescribing for Acute Sinusitis in Primary Care: A Cross-sectional Study. Clin Infect Dis 2021; 72:311-314. [PMID: 33501972 DOI: 10.1093/cid/ciaa736] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2020] [Accepted: 06/04/2020] [Indexed: 11/12/2022] Open
Abstract
The proportion of sinusitis visits that meet antibiotic prescribing criteria is unknown. Of 425 randomly selected sinusitis visits, 50% (214) met antibiotic prescribing criteria. There was no significant difference in antibiotic prescribing at visits that did (205/214 [96%]) and did not (193/211 [92%]; P = .07) meet antibiotic prescribing criteria.
Collapse
Affiliation(s)
- Katie N Truitt
- Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
| | - Tiffany Brown
- Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- Division of General Internal Medicine and Geriatrics, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
| | - Ji Young Lee
- Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- Division of General Internal Medicine and Geriatrics, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
| | - Jeffrey A Linder
- Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- Division of General Internal Medicine and Geriatrics, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
| |
Collapse
|
19
|
Naumov M, Reznichenko L, Masalykina Y, Styazhkin I. Antibiotic resistance is a common problem in medicine and veterinary. BIO WEB OF CONFERENCES 2021. [DOI: 10.1051/bioconf/20213700049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
This scientific article deals with the problem of antibiotic resistance. It is very difficult to give a complete picture of the resistance of microorganisms to antibiotics, because this topic is very diverse and is being actively investigated. Accordingly, information about more and more cases of antibiotic resistance appears very quickly. Less than a century has passed since the beginning of large-scale use of antibiotics. In this short historical period of time, the threat of antibiotic resistance has reached a global level, and it would be wrong to deny that it is humanity that has created such an enemy through its own efforts. Antibiotic resistance is a property of a microorganism that is associated with a decrease in the quality of the effect of an antibiotic on a given culture. The driving force behind this phenomenon is evolution. With the help of random mutations, an individual appears that is not susceptible to the effects of a previously used drug. The emergence of superbugs-cultures that do not respond to the use of currently existing antibiotics will lead to a decrease in the quality of life of people. Diseases that no longer caused concern in modern society will once again become deadly.
Collapse
|
20
|
Schwartz KL, Langford BJ, Daneman N, Chen B, Brown KA, McIsaac W, Tu K, Candido E, Johnstone J, Leung V, Hwee J, Silverman M, Wu JHC, Garber G. Unnecessary antibiotic prescribing in a Canadian primary care setting: a descriptive analysis using routinely collected electronic medical record data. CMAJ Open 2020; 8:E360-E369. [PMID: 32381687 PMCID: PMC7207032 DOI: 10.9778/cmajo.20190175] [Citation(s) in RCA: 39] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
BACKGROUND Unnecessary antibiotic use in the community in Canada is not well defined. Our objective was to quantify unnecessary antibiotic prescribing in a Canadian primary care setting. METHODS We performed a descriptive analysis in Ontario from April 2011 to March 2016 using the Electronic Medical Records Primary Care database linked to other health administrative data sets at ICES. We determined antibiotic prescribing rates (per 100 patient-physician encounters) for 23 common conditions and estimated rates of unnecessary prescribing using predefined expected prescribing rates, both stratified by condition and patient age group. RESULTS The study included 341 physicians, 204 313 patients and 499 570 encounters. The rate of unnecessary antibiotic prescribing for included conditions was 15.4% overall and was 17.6% for those less than 2 years of age, 18.6% for those aged 2-18, 14.5% for those aged 19-64 and 13.0% for those aged 65 or more. The highest unnecessary prescribing rates were observed for acute bronchitis (52.6%), acute sinusitis (48.4%) and acute otitis media (39.3%). The common cold, acute bronchitis, acute sinusitis and miscellaneous nonbacterial infections were responsible for 80% of the unnecessary antibiotic prescriptions. Of all antibiotics prescribed, 12.0% were for conditions for which they are never indicated, and 12.3% for conditions for which they are rarely indicated. In children, 25% of antibiotics were for conditions for which they are never indicated (e.g., common cold). INTERPRETATION Antibiotics were prescribed unnecessarily for 15.4% of included encounters in a Canadian primary care setting. Almost one-quarter of antibiotics were prescribed for conditions for which they are rarely or never indicated. These findings should guide safe reductions in the use of antibiotics for the common cold, bronchitis and sinusitis.
Collapse
Affiliation(s)
- Kevin L Schwartz
- Public Health Ontario (Schwartz, Langford, Brown, Johnstone, Leung, Wu, Garber); ICES Central (Schwartz, Daneman, Chen, Brown, Candido); Unity Health Network (Langford), St. Joseph Health Centre; Sunnybrook Research Institute (Daneman); Ray D. Wolfe Department of Family Medicine (McIsaac), Sinai Health System; Departments of Family & Community Medicine (McIsaac, Tu) and Laboratory Medicine and Pathobiology (Johnstone), University of Toronto; North York General Hospital (Tu); Toronto Western Hospital Family Health Team (Tu), University Health Network; Toronto East Health Network (Leung), Michael Garron Hospital; Dalla Lana School of Public Health (Hwee), University of Toronto, Toronto, Ont.; Institute for Better Health (Hwee), Trillium Health Partners, Mississauga, Ont.; London Health Sciences Centre (Silverman), London, Ont.; Ottawa Hospital Research Institute (Garber); Department of Medicine (Garber), University of Ottawa, Ottawa, Ont.
| | - Bradley J Langford
- Public Health Ontario (Schwartz, Langford, Brown, Johnstone, Leung, Wu, Garber); ICES Central (Schwartz, Daneman, Chen, Brown, Candido); Unity Health Network (Langford), St. Joseph Health Centre; Sunnybrook Research Institute (Daneman); Ray D. Wolfe Department of Family Medicine (McIsaac), Sinai Health System; Departments of Family & Community Medicine (McIsaac, Tu) and Laboratory Medicine and Pathobiology (Johnstone), University of Toronto; North York General Hospital (Tu); Toronto Western Hospital Family Health Team (Tu), University Health Network; Toronto East Health Network (Leung), Michael Garron Hospital; Dalla Lana School of Public Health (Hwee), University of Toronto, Toronto, Ont.; Institute for Better Health (Hwee), Trillium Health Partners, Mississauga, Ont.; London Health Sciences Centre (Silverman), London, Ont.; Ottawa Hospital Research Institute (Garber); Department of Medicine (Garber), University of Ottawa, Ottawa, Ont
| | - Nick Daneman
- Public Health Ontario (Schwartz, Langford, Brown, Johnstone, Leung, Wu, Garber); ICES Central (Schwartz, Daneman, Chen, Brown, Candido); Unity Health Network (Langford), St. Joseph Health Centre; Sunnybrook Research Institute (Daneman); Ray D. Wolfe Department of Family Medicine (McIsaac), Sinai Health System; Departments of Family & Community Medicine (McIsaac, Tu) and Laboratory Medicine and Pathobiology (Johnstone), University of Toronto; North York General Hospital (Tu); Toronto Western Hospital Family Health Team (Tu), University Health Network; Toronto East Health Network (Leung), Michael Garron Hospital; Dalla Lana School of Public Health (Hwee), University of Toronto, Toronto, Ont.; Institute for Better Health (Hwee), Trillium Health Partners, Mississauga, Ont.; London Health Sciences Centre (Silverman), London, Ont.; Ottawa Hospital Research Institute (Garber); Department of Medicine (Garber), University of Ottawa, Ottawa, Ont
| | - Branson Chen
- Public Health Ontario (Schwartz, Langford, Brown, Johnstone, Leung, Wu, Garber); ICES Central (Schwartz, Daneman, Chen, Brown, Candido); Unity Health Network (Langford), St. Joseph Health Centre; Sunnybrook Research Institute (Daneman); Ray D. Wolfe Department of Family Medicine (McIsaac), Sinai Health System; Departments of Family & Community Medicine (McIsaac, Tu) and Laboratory Medicine and Pathobiology (Johnstone), University of Toronto; North York General Hospital (Tu); Toronto Western Hospital Family Health Team (Tu), University Health Network; Toronto East Health Network (Leung), Michael Garron Hospital; Dalla Lana School of Public Health (Hwee), University of Toronto, Toronto, Ont.; Institute for Better Health (Hwee), Trillium Health Partners, Mississauga, Ont.; London Health Sciences Centre (Silverman), London, Ont.; Ottawa Hospital Research Institute (Garber); Department of Medicine (Garber), University of Ottawa, Ottawa, Ont
| | - Kevin A Brown
- Public Health Ontario (Schwartz, Langford, Brown, Johnstone, Leung, Wu, Garber); ICES Central (Schwartz, Daneman, Chen, Brown, Candido); Unity Health Network (Langford), St. Joseph Health Centre; Sunnybrook Research Institute (Daneman); Ray D. Wolfe Department of Family Medicine (McIsaac), Sinai Health System; Departments of Family & Community Medicine (McIsaac, Tu) and Laboratory Medicine and Pathobiology (Johnstone), University of Toronto; North York General Hospital (Tu); Toronto Western Hospital Family Health Team (Tu), University Health Network; Toronto East Health Network (Leung), Michael Garron Hospital; Dalla Lana School of Public Health (Hwee), University of Toronto, Toronto, Ont.; Institute for Better Health (Hwee), Trillium Health Partners, Mississauga, Ont.; London Health Sciences Centre (Silverman), London, Ont.; Ottawa Hospital Research Institute (Garber); Department of Medicine (Garber), University of Ottawa, Ottawa, Ont
| | - Warren McIsaac
- Public Health Ontario (Schwartz, Langford, Brown, Johnstone, Leung, Wu, Garber); ICES Central (Schwartz, Daneman, Chen, Brown, Candido); Unity Health Network (Langford), St. Joseph Health Centre; Sunnybrook Research Institute (Daneman); Ray D. Wolfe Department of Family Medicine (McIsaac), Sinai Health System; Departments of Family & Community Medicine (McIsaac, Tu) and Laboratory Medicine and Pathobiology (Johnstone), University of Toronto; North York General Hospital (Tu); Toronto Western Hospital Family Health Team (Tu), University Health Network; Toronto East Health Network (Leung), Michael Garron Hospital; Dalla Lana School of Public Health (Hwee), University of Toronto, Toronto, Ont.; Institute for Better Health (Hwee), Trillium Health Partners, Mississauga, Ont.; London Health Sciences Centre (Silverman), London, Ont.; Ottawa Hospital Research Institute (Garber); Department of Medicine (Garber), University of Ottawa, Ottawa, Ont
| | - Karen Tu
- Public Health Ontario (Schwartz, Langford, Brown, Johnstone, Leung, Wu, Garber); ICES Central (Schwartz, Daneman, Chen, Brown, Candido); Unity Health Network (Langford), St. Joseph Health Centre; Sunnybrook Research Institute (Daneman); Ray D. Wolfe Department of Family Medicine (McIsaac), Sinai Health System; Departments of Family & Community Medicine (McIsaac, Tu) and Laboratory Medicine and Pathobiology (Johnstone), University of Toronto; North York General Hospital (Tu); Toronto Western Hospital Family Health Team (Tu), University Health Network; Toronto East Health Network (Leung), Michael Garron Hospital; Dalla Lana School of Public Health (Hwee), University of Toronto, Toronto, Ont.; Institute for Better Health (Hwee), Trillium Health Partners, Mississauga, Ont.; London Health Sciences Centre (Silverman), London, Ont.; Ottawa Hospital Research Institute (Garber); Department of Medicine (Garber), University of Ottawa, Ottawa, Ont
| | - Elisa Candido
- Public Health Ontario (Schwartz, Langford, Brown, Johnstone, Leung, Wu, Garber); ICES Central (Schwartz, Daneman, Chen, Brown, Candido); Unity Health Network (Langford), St. Joseph Health Centre; Sunnybrook Research Institute (Daneman); Ray D. Wolfe Department of Family Medicine (McIsaac), Sinai Health System; Departments of Family & Community Medicine (McIsaac, Tu) and Laboratory Medicine and Pathobiology (Johnstone), University of Toronto; North York General Hospital (Tu); Toronto Western Hospital Family Health Team (Tu), University Health Network; Toronto East Health Network (Leung), Michael Garron Hospital; Dalla Lana School of Public Health (Hwee), University of Toronto, Toronto, Ont.; Institute for Better Health (Hwee), Trillium Health Partners, Mississauga, Ont.; London Health Sciences Centre (Silverman), London, Ont.; Ottawa Hospital Research Institute (Garber); Department of Medicine (Garber), University of Ottawa, Ottawa, Ont
| | - Jennie Johnstone
- Public Health Ontario (Schwartz, Langford, Brown, Johnstone, Leung, Wu, Garber); ICES Central (Schwartz, Daneman, Chen, Brown, Candido); Unity Health Network (Langford), St. Joseph Health Centre; Sunnybrook Research Institute (Daneman); Ray D. Wolfe Department of Family Medicine (McIsaac), Sinai Health System; Departments of Family & Community Medicine (McIsaac, Tu) and Laboratory Medicine and Pathobiology (Johnstone), University of Toronto; North York General Hospital (Tu); Toronto Western Hospital Family Health Team (Tu), University Health Network; Toronto East Health Network (Leung), Michael Garron Hospital; Dalla Lana School of Public Health (Hwee), University of Toronto, Toronto, Ont.; Institute for Better Health (Hwee), Trillium Health Partners, Mississauga, Ont.; London Health Sciences Centre (Silverman), London, Ont.; Ottawa Hospital Research Institute (Garber); Department of Medicine (Garber), University of Ottawa, Ottawa, Ont
| | - Valerie Leung
- Public Health Ontario (Schwartz, Langford, Brown, Johnstone, Leung, Wu, Garber); ICES Central (Schwartz, Daneman, Chen, Brown, Candido); Unity Health Network (Langford), St. Joseph Health Centre; Sunnybrook Research Institute (Daneman); Ray D. Wolfe Department of Family Medicine (McIsaac), Sinai Health System; Departments of Family & Community Medicine (McIsaac, Tu) and Laboratory Medicine and Pathobiology (Johnstone), University of Toronto; North York General Hospital (Tu); Toronto Western Hospital Family Health Team (Tu), University Health Network; Toronto East Health Network (Leung), Michael Garron Hospital; Dalla Lana School of Public Health (Hwee), University of Toronto, Toronto, Ont.; Institute for Better Health (Hwee), Trillium Health Partners, Mississauga, Ont.; London Health Sciences Centre (Silverman), London, Ont.; Ottawa Hospital Research Institute (Garber); Department of Medicine (Garber), University of Ottawa, Ottawa, Ont
| | - Jeremiah Hwee
- Public Health Ontario (Schwartz, Langford, Brown, Johnstone, Leung, Wu, Garber); ICES Central (Schwartz, Daneman, Chen, Brown, Candido); Unity Health Network (Langford), St. Joseph Health Centre; Sunnybrook Research Institute (Daneman); Ray D. Wolfe Department of Family Medicine (McIsaac), Sinai Health System; Departments of Family & Community Medicine (McIsaac, Tu) and Laboratory Medicine and Pathobiology (Johnstone), University of Toronto; North York General Hospital (Tu); Toronto Western Hospital Family Health Team (Tu), University Health Network; Toronto East Health Network (Leung), Michael Garron Hospital; Dalla Lana School of Public Health (Hwee), University of Toronto, Toronto, Ont.; Institute for Better Health (Hwee), Trillium Health Partners, Mississauga, Ont.; London Health Sciences Centre (Silverman), London, Ont.; Ottawa Hospital Research Institute (Garber); Department of Medicine (Garber), University of Ottawa, Ottawa, Ont
| | - Michael Silverman
- Public Health Ontario (Schwartz, Langford, Brown, Johnstone, Leung, Wu, Garber); ICES Central (Schwartz, Daneman, Chen, Brown, Candido); Unity Health Network (Langford), St. Joseph Health Centre; Sunnybrook Research Institute (Daneman); Ray D. Wolfe Department of Family Medicine (McIsaac), Sinai Health System; Departments of Family & Community Medicine (McIsaac, Tu) and Laboratory Medicine and Pathobiology (Johnstone), University of Toronto; North York General Hospital (Tu); Toronto Western Hospital Family Health Team (Tu), University Health Network; Toronto East Health Network (Leung), Michael Garron Hospital; Dalla Lana School of Public Health (Hwee), University of Toronto, Toronto, Ont.; Institute for Better Health (Hwee), Trillium Health Partners, Mississauga, Ont.; London Health Sciences Centre (Silverman), London, Ont.; Ottawa Hospital Research Institute (Garber); Department of Medicine (Garber), University of Ottawa, Ottawa, Ont
| | - Julie H C Wu
- Public Health Ontario (Schwartz, Langford, Brown, Johnstone, Leung, Wu, Garber); ICES Central (Schwartz, Daneman, Chen, Brown, Candido); Unity Health Network (Langford), St. Joseph Health Centre; Sunnybrook Research Institute (Daneman); Ray D. Wolfe Department of Family Medicine (McIsaac), Sinai Health System; Departments of Family & Community Medicine (McIsaac, Tu) and Laboratory Medicine and Pathobiology (Johnstone), University of Toronto; North York General Hospital (Tu); Toronto Western Hospital Family Health Team (Tu), University Health Network; Toronto East Health Network (Leung), Michael Garron Hospital; Dalla Lana School of Public Health (Hwee), University of Toronto, Toronto, Ont.; Institute for Better Health (Hwee), Trillium Health Partners, Mississauga, Ont.; London Health Sciences Centre (Silverman), London, Ont.; Ottawa Hospital Research Institute (Garber); Department of Medicine (Garber), University of Ottawa, Ottawa, Ont
| | - Gary Garber
- Public Health Ontario (Schwartz, Langford, Brown, Johnstone, Leung, Wu, Garber); ICES Central (Schwartz, Daneman, Chen, Brown, Candido); Unity Health Network (Langford), St. Joseph Health Centre; Sunnybrook Research Institute (Daneman); Ray D. Wolfe Department of Family Medicine (McIsaac), Sinai Health System; Departments of Family & Community Medicine (McIsaac, Tu) and Laboratory Medicine and Pathobiology (Johnstone), University of Toronto; North York General Hospital (Tu); Toronto Western Hospital Family Health Team (Tu), University Health Network; Toronto East Health Network (Leung), Michael Garron Hospital; Dalla Lana School of Public Health (Hwee), University of Toronto, Toronto, Ont.; Institute for Better Health (Hwee), Trillium Health Partners, Mississauga, Ont.; London Health Sciences Centre (Silverman), London, Ont.; Ottawa Hospital Research Institute (Garber); Department of Medicine (Garber), University of Ottawa, Ottawa, Ont
| |
Collapse
|
21
|
Macy E. Addressing the epidemic of antibiotic "allergy" over-diagnosis. Ann Allergy Asthma Immunol 2019; 124:550-557. [PMID: 31881269 DOI: 10.1016/j.anai.2019.12.016] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2019] [Revised: 12/04/2019] [Accepted: 12/16/2019] [Indexed: 12/20/2022]
Abstract
OBJECTIVE An epidemic of antibiotic allergy is occurring. DATA SOURCES Articles published since 2008. STUDY SELECTIONS Articles on antibiotic allergy and stewardship. RESULTS A number of overlapping factors contribute. The most important factor is antibiotic overuse. Antibiotics are commonly used in situations in which no antibiotics are indicated. Thirty percent to 50% of ambulatory antibiotic use may be inappropriate. The duration of indicated antibiotic use is often excessive, which leads to more side effects. All antibiotic use can result in adverse reactions, and a fraction of these will be dutifully recorded as an allergy in the electronic health record (EHR). Most EHRs are not well structured to accurately convey information on expected side effects that have occurred, metabolic or other contraindications, dose-related or situational toxicities, personal preferences, clinically significant immunologically mediated hypersensitivity, and other reasons a particular patient may not want or should not be given a specific drug or type of drug in the future. As populations age, their accumulated baggage of reported antibiotic allergies increase. Suspected antibiotic allergy is rarely confirmed with appropriate testing or rechallenge. Patients then receive suboptimal antibiotic therapy and experience more side effects, treatment failures, and serious antibiotic-resistant infections. Reporting an antibiotic allergy in the EHR is nominally done to improve patient safety, but unfortunately, this is often not the actual result. CONCLUSION Audit and feedback, to help ensure adherence to Choosing Wisely recommendations and good antibiotic stewardship practices, can help reduce inappropriate antibiotic use. Restructuring EHRs to facilitate correct drug intolerance reporting, along with active antibiotic allergy delabeling programs, can help stem this epidemic.
Collapse
Affiliation(s)
- Eric Macy
- Department of Allergy, Southern California Permanente Medical Group, San Diego Medical Center, San Diego, California.
| |
Collapse
|